Membrane proteomic analysis comparing squamous cell lung cancer tissue and tumour-adjacent normal tissue

Cancer Letters

Volumn 319, Issue 1, 2012, Pages 118-124

  Li, Burong ^a   Chang, Jiantong ^a   Chu, Yonglie ^a   Kang, Huafeng ^b   Yang, Jun ^b   Jiang, Jiantao ^b   Ma, Hongbin ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

MALDI TOF MS; Membrane proteomics; Squamous cell lung carcinoma

Indexed keywords

PROTEOME;

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CANCER TISSUE; CELL MEMBRANE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEMBRANE PROTEOMICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPARATION TECHNIQUE; SQUAMOUS CELL CARCINOMA; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84862782067     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.12.037     Document Type: Article

References (22)

1. Esposito L., Conti D., Ailavajhala R., Khalil N., Giordano A. Are we up to the challenge? Current genomics. Lung Cancer 2010, 7:513-518.
2. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics. CA Cancer J. Clin. 2002, 2(2005):74-108.
3. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics. CA Cancer J. Clin. 2007, 57(2007):43-66.
4. Rarni-Porta R., Crowley J.J., Goldstraw P. The revised TNM staging system for lung cancer. Ann. Thorac. Cardiovasc. Surg. 2009, 15:4-9.
5. Ludwig J.A., Weinstein J.N. Biomarkers in cancer staging, prognosis and treatment selection. Nat. Rev. Cancer 2005, 5:845-856.
6. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422:198-207.
7. Kulasingam V., Diamandis E.P. Strategies for discovering novel cancer biomarkers through utilisation of emerging technologies. Nat. Clin. Pract. Oncol. 2008, 5:588-599.
8. Cravatt B.F., Simon G.M., Yates J.R. The biological impact of mass-spectrometry-based proteomics. Nature 2007, 450:991-1000.
9. Dowling P., Meleady P., Dowd A., Henry M., Glynn S., Clynes M. Proteomic analysis of isolated membrane fractions from superinvasive cancer cells. Biochim. Biophys. Acta 2007, 1:93-101.
10. Speers A.E., Wu C.C. Proteomics of integral membrane proteins-theory and application. Chem. Rev. 2007, 107:3687-3714.
11. Wu C.C., Yates J.R. The application of mass spectrometry to membrane proteomics. Nat. Biotechnol. 2003, 3:262-267.
12. Weekes M.P., Antrobus R., Lill J.R., Duncan L.M., Hör S., Lehner P.J. Comparative analysis of techniques to purify plasma membrane proteins. J. Biomol. Technol. 2010, 3:108-115.
13. Zhang L., Jia X., Liu X., Sheng T., Cao R., He Q., Liu Z., Peng X., Xiong J., Zhang P. Dataset of the plasma membrane proteome of nasopharyngeal carcinoma cell line HNE1 for uncovering protein function. Acta Biochim. Biophys. Sin. 2008, 40:55-70.
14. Zhang Z., Zhang L., Hua Y., Jia X., Li J., Hu S., Peng X., Yang P., Sun M., Ma F., Cai Z. Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines. BMC Cancer 2010, 14:206.
15. Lee K.B., Pi K.B. Comparative proteomic analysis of cancerous and adjacent normal lung tissues. Biomed. Khim. 2010, 56:663-673.
16. Oberg A.L., Vitek O. Statistical design of quantitative mass spectrometry-based proteomic experiments. J. Proteome Res. 2009, 5:2144-2156.
17. Diamandis E.P. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps. Cancer Res. 2006, 66:540-541.
18. Leth-Larsen R., Lund R.R., Ditzel H.J. Plasma membrane proteomics and its application in clinical cancer biomarker discovery. Mol. Cell Proteomics 2010, 9:1369-1382.
19. Liu Y.F., Xiao Z.Q., Li M.X., Li M.Y., Zhang P.F., Li C., Li F., Chen Y.H., Yi H., Yao H.X., Chen Z.C. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J. Pathol. 2009, 217:54-64.
20. Patriarca E.J., Maresca B. Acquired thermotolerance following heat shock protein synthesis prevents impairment of mitochondrial ATPase activity at elevated temperatures in Saccharomyces cerevisiae. Exp. Cell Res. 1990, 190:57-64.
21. Czarnecka A.M., Campanella C., Zummo G., Cappello F. Mitochondrial chaperones in cancer: from molecular biology to clinical diagnostics. Cancer Biol. Ther. 2006, 5:714-720.
22. Cheng A.L., Huang W.G., Chen Z.C., Zhang P.F., Li M.Y., Li F., Li J.L., Li C., Yi H., Peng F., Duan C.J., Xiao Z.Q. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J. Proteome Res. 2008, 7:2415-2426.